Abstract

PurposeHuman leukocyte antigen (HLA) and immunity are related. Uveitis is also closely related to immunity. For example, the common presence of human leukocyte antigen (HLA)-DRB1*04 in the immune response is well known. The aim of this study was to investigate the relationship between visual prognosis and various HLA alleles before and after therapy in patients with unclassifiable uveitis, excluding those with Vogt-Koyanagi-Harada (VKH) disease.MethodsThis retrospective case series included 42 eyes from 22 consecutive patients with unclassifiable uveitis, excluding those with VKH disease. Visual acuity (VA), sex, refractive error, central retinal thickness (CRT), central choroidal thickness (CCT), and duration from onset to treatment were measured at initial and 6-month visits. Mean values of parameters were compared at each visit. Genotyping was performed by polymerase chain reaction amplification with sequence-specific primers.ResultsDRB1*04 showed a dominant change. No significant difference was observed in the other alleles. In DRB1*04, The mean differences in initial CCT, 6-month CCT, and 6-month VA showed statistically significant difference was found in best-corrected visual acuity (BCVA) between DRB1*04+ and DRB1*04− at the first visit. BCVA values at baseline and at the final visit were 0.13 ± 0.29 and 0.20 ± 0.36 in the DRB1*04+ and 0.00045 ± 0.20 and − 0.058 ± 0.11 in the DRB1*04− groups(p = 0.00465). Central Choroidal Thickness (CCT) values pretreatment and at the final visit after treatment were (pretreatment:361.00 ± 361.0 μm,after treatment: 286.00 ± 106.53 μm, p = 0.0174) in the DRB1*04+ group, and (pretreatment:281.3 ± 139.68 μm,after treatment:223.85 ± 99.034 μm, p = 0.0426) in the DRB1*04− group, respectively, indicating changes between baseline and the final visit. CCT was significantly greater in the DRB1*04+ group at both the initial visit and at 6 months. Multivariate analysis showed a significant difference between the presence or absence of DRB1*04 and sex.ConclusionHLA-DRB1*04 allele may affect visual prognosis and CCT in unclassifiable uveitis.

Highlights

  • Uveitis is an inflammatory condition of the iris, ciliary body, choroid, and surrounding tissues [1]

  • In DRB1*04, The mean differences in initial central choroidal thickness (CCT), 6-month CCT, and 6-month Visual acuity (VA) showed statistically significant difference was found in best-corrected visual acuity (BCVA) between DRB1*04+ and DRB1*04− at the first visit

  • We investigated whether changes in visual functions and ocular structures are associated with various Human leukocyte antigen (HLA) in unclassifiable uveitis, excluding VKH disease, in east Asian patients

Read more

Summary

Introduction

Uveitis is an inflammatory condition of the iris, ciliary body, choroid, and surrounding tissues [1]. The most common cause of uveitis in Japan is sarcoidosis, Misawa et al BMC Ophthalmology (2021) 21:457 followed by Vogt-Koyanagi-Harada (VKH) disease. Other common conditions include Behçet’s disease, acute anterior uveitis, scleritis, and herpetic iritis [2,3,4]. The pathogenesis of uveitis involves an immune system imbalance and the genetic background [8,9,10]. Some kind of systemic immune-disease including Rheumatic disease were associated with Human leukocyte antigen (HLA) [11, 12]. HLA is the most common genetic background for several types of uveitis [8, 13]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call